Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Tweet
Print
Don Wang, n/a
Director, Biostatistics/Programming
Akebia Therapeutics Inc
Poster(s):
064: A Phase 1b, Randomized, Open-Label Study to Evaluate the Pharmacokinetics, Pharmacodynamics & Safety of Vadadustat in Hemodialysis Patients With Anemia Associated With Chronic Kidney Disease
Sunday, September 10, 2023
5:00 PM - 7:00 PM
PT
